The Phage Therapy Market growth Market growth is primarily driven by the increasing prevalence of antibiotic-resistant bacterial infections worldwide. As conventional antibiotics become less effective, healthcare providers are actively exploring alternative treatment options, with phage therapy emerging as a highly promising solution. The ability of bacteriophages to selectively target bacterial pathogens without harming human cells is a major advantage that supports its growing acceptance in clinical research and experimental treatments.

Moreover, advancements in genomic sequencing and bioinformatics are enabling faster identification and customization of phage treatments. This has significantly improved treatment precision and reduced development time for new therapies. The rising focus on personalized medicine is also contributing to market expansion, as phage therapy can be tailored to individual bacterial infections. Increased funding from government agencies and private investors is further accelerating innovation and clinical trials in this sector

FAQ

Q1: What is the main growth driver?
A1: Antibiotic resistance.

Q2: Why is phage therapy important?
A2: It provides targeted bacterial treatment.

Q3: Is personalized treatment possible?
A3: Yes, phage therapy can be customized.